133 related articles for article (PubMed ID: 8004841)
1. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
[TBL] [Abstract][Full Text] [Related]
2. Low-dose bisoprolol/hydrochlorothiazide: an option in first-line, antihypertensive treatment.
Zachariah PK; Messerli FH; Mroczek W
Clin Ther; 1993; 15(5):779-87. PubMed ID: 8269444
[TBL] [Abstract][Full Text] [Related]
3. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
[TBL] [Abstract][Full Text] [Related]
4. Beta-blocker/thiazide combination for treatment of hypertensive children: a randomized double-blind, placebo-controlled trial.
Sorof JM; Cargo P; Graepel J; Humphrey D; King E; Rolf C; Cunningham RJ
Pediatr Nephrol; 2002 May; 17(5):345-50. PubMed ID: 12042891
[TBL] [Abstract][Full Text] [Related]
5. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
Frishman WH; Bryzinski BS; Coulson LR; DeQuattro VL; Vlachakis ND; Mroczek WJ; Dukart G; Goldberg JD; Alemayehu D; Koury K
Arch Intern Med; 1994 Jul; 154(13):1461-8. PubMed ID: 8018001
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
[TBL] [Abstract][Full Text] [Related]
7. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension.
Frishman WH; Burris JF; Mroczek WJ; Weir MR; Alemayehu D; Simon JS; Chen SY; Bryzinski BS
J Clin Pharmacol; 1995 Feb; 35(2):182-8. PubMed ID: 7751430
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.
Suojanen L; Haring A; Tikkakoski A; Koskela JK; Tahvanainen AM; Huhtala H; Kähönen M; Sipilä K; Eräranta A; Mustonen JT; Kivistö K; Pörsti IH
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):130-137. PubMed ID: 28256104
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
Lewin AJ; Lueg MC; Targum S; Cardenas P
Clin Cardiol; 1993 Oct; 16(10):732-6. PubMed ID: 8222387
[TBL] [Abstract][Full Text] [Related]
11. Multicenter evaluation of the hemodynamic effects of bisoprolol in patients with mild to moderate hypertension.
Prisant LM; Carr AA; Desnoyers M; Westcott RJ; Zinny MA; O'Donnell DM; Bryzinski B; McKee B; Nelson BR
J Clin Pharmacol; 1990 Dec; 30(12):1096-101. PubMed ID: 1980278
[TBL] [Abstract][Full Text] [Related]
12. [The antihypertensive effect of the new cardioselective prolonged-action beta-adrenoblocker bisoprolol compared with propranolol, metoprolol and placebo].
Metelitsa VI; Duda SG; Gorbunov VM; Buchner-Moll D; Deev AD; Vygodin VA; Filatova NP; Chel'dieva EIa; Shastun RS; Simonov DV
Eksp Klin Farmakol; 1995; 58(2):32-4. PubMed ID: 7773086
[TBL] [Abstract][Full Text] [Related]
13. Quality of life comparison between bisoprolol and nifedipine retard in hypertension.
de Hoon JN; Vanmolkot FH; van de Ven LL; Van Bortel LM
Cardiovasc Drugs Ther; 1997 Jul; 11(3):465-71. PubMed ID: 9310275
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of bisoprolol 5 mg plus amlodipine 5 mg in patients with hypertension uncontrolled on monotherapy with 5 mg of amlodipine, a phase III multicenter, randomized, double-blind, placebo-controlled clinical trial - the AMCOR study.
Jędrusik P; Placha G; Gaciong Z;
Curr Med Res Opin; 2023 Jul; 39(7):939-946. PubMed ID: 37300442
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study.
Matsuoka H; Kuwajima I; Shimada K; Mitamura H; Saruta T
J Clin Hypertens (Greenwich); 2013 Nov; 15(11):806-14. PubMed ID: 24119112
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
[TBL] [Abstract][Full Text] [Related]
17. Three years of experience with bisoprolol in the treatment of mild to moderate hypertension.
Giesecke HG; Buchner-Möll D
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S175-8. PubMed ID: 11527123
[TBL] [Abstract][Full Text] [Related]
18. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
[TBL] [Abstract][Full Text] [Related]
19. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
[TBL] [Abstract][Full Text] [Related]
20. Quality of life perception during antihypertensive treatment: a comparative study of bisoprolol and enalapril.
Breed JG; Ciampricotti R; Tromp GP; Valster FA; Lageweg E; Van Bortel LM
J Cardiovasc Pharmacol; 1992; 20(5):750-5. PubMed ID: 1280737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
